Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 34.80% vs -10.46% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 150.09% vs -113.11% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is 736.17% vs -110.98% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is -60.00% vs 94.44% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Sichuan Huiyu Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 34.80% vs -10.46% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -9.70% vs 53.21% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 150.09% vs -113.11% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -82.03% vs 685.15% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is 736.17% vs -110.98% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -53.57% vs 666.67% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -60.00% vs 94.44% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -53.33% vs 275.00% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






